玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

TAK-220

    
≥98%

TAK-220

源葉(MedMol)
S84980 一鍵復制產品信息
333994-00-6
C31H41ClN4O3
553.1353
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S84980-1mg
≥98% ¥1500.00 貨期:2-3天 - - -
S84980-5mg
≥98% ¥3500.00 貨期:2-3天 - - -
S84980-10mg
≥98% ¥5000.00 貨期:2-3天 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

TAK-220 is a selective and orally bioavailable CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7; TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs.

產品描述: TAK-220 is a selective and orally bioavailable CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7; TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs.
靶點: MIP-1α-CCR5:1.4 nM (IC50, in CHO cells);RANTES-CCR5:3.5 nM (IC50, in CHO cells);HIV-1 (HHA):0.55 nM (EC50, in PBMCs);HIV-1 (CTV):0.72 nM (EC50, in PBMCs);HIV-1 (HTN):0.93 nM (EC50, in PBMCs);HIV-1 (KK):1.2 nM (EC50, in PBMCs);HIV-1 (HKW):1.7 nM (EC50, in PBMCs);HIV-1 (HNK):1.7 nM (EC50, in PBMCs);HIV-1 (HHA):4 nM (EC90, in PBMCs);HIV-1 (CTV):5 nM (EC90, in PBMCs);HIV-1 (KK):12 nM (EC90, in PBMCs);HIV-1 (HKW):12 nM (EC90, in PBMCs);HIV-1 (HTN):15 nM (EC90, in PBMCs);HIV-1 (HNK):28 nM (EC90, in PBMCs);HIVProt
體外研究: TAK-220 is a selective CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5 in CHO cells, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7. TAK-220 (0-1000 nM) interacts with CCR5 but not with RANTES and inhibits the CCR5-mediated Casup>2+ signaling. TAK-220 inhibits R5 HIV-1 (JR-FL) envelope-mediated membrane fusion, with an IC50 value of 0.42 nM, but does not alter X4 HIV-1 (HXB2) envelope-mediated membrane fusion. TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs. TAK-220 shows potent inhibitory activity against the R5 isolates, with IC50s of 3.12 nM against HIV-1 R5-08, 13.47 nM against HIV-1 R5-06, and 2.26 nM against HIV-1 R5-18. TAK-220 (>100 nM) has no toxicity in uninfected PBMCs
參考文獻: 1. Takashima K, et al. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. Antimicrob Agents Chemother. 2005 Aug;49(8):3474-82. 2. Tremblay CL, et al. TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro. Antimicrob Agents Chemother. 2005 Aug;49(8):3483-5.
溶解性: Soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.808 ml 9.039 ml 18.079 ml
5 mM 0.362 ml 1.808 ml 3.616 ml
10 mM 0.181 ml 0.904 ml 1.808 ml
50 mM 0.036 ml 0.181 ml 0.362 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: SHOW| 晴隆县| 蒙山县| 稻城县| 余江县| 慈溪市| 启东市| 隆子县| 泾源县| 平江县| 隆尧县| 东源县| 唐山市| 四会市| 六盘水市| 亳州市| 新野县| 阳江市| 江门市| 屏东市| 五莲县| 利辛县| 绥江县| 新郑市| 迁安市| 保定市| 汤原县| 三穗县| 阳城县| 开原市| 德安县| 淄博市| 达孜县| 杨浦区| 平利县| 奉贤区| 闽清县| 宝山区| 清流县| 秦皇岛市| 扬中市|